Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

On Tuesday, Citi analysts initiated a 90-day downside short-term view on Illumina stock (NASDAQ:ILMN), citing several significant challenges that the company is currently facing. The stock has already ...

Tuesday, Wolfe Research analysts maintained their Outperform rating on Illumina stock (NASDAQ:ILMN), keeping the price target at $150.00 despite recent developments. Currently trading at $88.74, the ...

On Tuesday, Citi analysts initiated a 90-day downside short-term view on Illumina stock (NASDAQ:ILMN), citing several significant challenges that the company is currently facing. The stock has ...

On February 24, 2025, Illumina, Inc. (NASDAQ:ILMN) stock closed at $93.96 per share with a market capitalization of $9.978 billion. Baron Fifth Avenue Growth Fund stated the following regarding ...

SAN DIEGO - Illumina, Inc. (NASDAQ: NASDAQ:ILMN), a $4.37 billion revenue genomics leader with an impressive 68.37% gross margin, today announced a comprehensive suite of new omics technologies, ...